Lion Point Capital’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-208,695	Closed	-$1.14M	–	36
2022 Q2	$1.14M	Hold	208,695	–	–	0.13%	27
2022 Q1	$1.57M	Buy	+208,695	New	+$1.57M	0.36%	22
2021 Q4	–	Sell	-208,333	Closed	-$3.4M	–	30
2021 Q3	$3.4M	Buy	+208,333	New	+$3.4M	0.64%	22